"10.1371_journal.pone.0130907","plos one","2015-06-24T00:00:00Z","Heiko Schotte; Bernhard Schlüter; Hartmut Schmidt; Markus Gaubitz; Susanne Drynda; Jörn Kekow; Peter Willeke","Niels-Stensen-Kliniken, Franziskus-Hospital Harderberg, Georgsmarienhütte, Germany; Centrum für Laboratoriumsmedizin, Universitätsklinkum Münster, Münster, Germany; Akademie für Manuelle Medizin, Rheumatologie, Münster, Germany; Klinik für Rheumatologie, Universität Magdeburg, Vogelsang / Gommern, Germany; Medizinische Klinik D, Universitätsklinikum Münster, Münster, Germany","Conceived and designed the experiments: H. Schotte BS. Performed the experiments: H. Schmidt MG SD JK. Analyzed the data: H. Schotte BS PW. Contributed reagents/materials/analysis tools: H. Schmidt. Wrote the paper: H. Schotte BS PW.","Etanercept was provided by Pfizer Deutschland GmbH, Germany. Before long-term treatment with stable standard doses of etanercept, patients included in the present analysis started in placebo controlled trials that were sponsored by Pfizer. Markus Gaubitz, Jörn Kekow and Peter Willeke received speaking fees from Pfizer Deutschland GmbH. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","06","Heiko Schotte","HS",7,TRUE,1,1,1,1,TRUE,TRUE,TRUE,5,"2;4;5;6;7",TRUE
